[1] CUNNINGHAM V L, BINKS S P, OLSON M J, et al. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment[J]. Regulatory Toxicology and Pharmacology, 2009, 53: 39-45. doi: 10.1016/j.yrtph.2008.10.006
[2] BEAN T G, RATTNER B A, LAZARUS R S, et al. Pharmaceuticals in water, fish and osprey nestlings in Delaware River and Bay[J]. Environmental Pollution, 2018, 232: 533-545. doi: 10.1016/j.envpol.2017.09.083
[3] MANJARRÉS-LÓPEZ D P, PEÑA-HERRERA J M, BENEJAM L, et al. Assessment of wastewater-borne pharmaceuticals in tissues and body fluids from riverine fish[J]. Environmental Pollution, 2023, 324: 121374. doi: 10.1016/j.envpol.2023.121374
[4] 张晶晶, 陈娟, 王沛芳, 等. 中国典型湖泊四大类抗生素污染特征[J]. 中国环境科学, 2021, 41(9): 4271-4283. doi: 10.3969/j.issn.1000-6923.2021.09.034
[5] 樊月婷, 昌盛, 张坤锋, 等. 疫情背景下长江中游地区典型饮用水源中PPCPs分布特征与风险评估[J]. 环境科学, 2022, 43(12): 5522-5533.
[6] 宁光. 中国糖尿病防治的现状及展望[J]. 中国科学: 生命科学, 2018, 48(8): 810-811.
[7] 马丽媛, 王增武, 樊静, 等. 《中国心血管健康与疾病报告2021》概要[J]. 中国介入心脏病学杂志, 2022, 30(7): 481-496. doi: 10.3969/j.issn.1004-8812.2022.07.001
[8] MA R X, WANG B, YIN L N, et al. Characterization of pharmaceutically active compounds in Beijing, China: Occurrence pattern, spatiotemporal distribution and its environmental implication[J]. Journal of Hazardous Materials, 2017, 323: 147-155. doi: 10.1016/j.jhazmat.2016.05.030
[9] YANG X, CHEN F, MENG F G, et al. Occurrence and fate of PPCPs and correlations with water quality parameters in urban riverine waters of the Pearl River Delta, South China[J]. Environmental Science and Pollution Research, 2013, 20: 5864-5875. doi: 10.1007/s11356-013-1641-x
[10] 刘娴静, 梁存珍, 肖本益, 等. 高效液相色谱-串联质谱法同时检测水体中26种药物及个人护理品[J]. 环境化学, 2021, 40(2): 549-558. doi: 10.7524/j.issn.0254-6108.2019092706
[11] 高欲乾, 郭敏丽, 梁存珍, 等. 水体中17种持久性和可迁移有机污染物的检测[J]. 环境工程学报, 2023, 17(5): 1736-1746. doi: 10.12030/j.cjee.202301066
[12] 褚莹倩, 陈溪, 张晓林, 等. 中国地表水环境中药物与个人护理品生态风险评价的研究进展[J]. 生态毒理学报, 2021, 16(4): 80-92. doi: 10.7524/AJE.1673-5897.20201010001
[13] SANTOS L H, ARAÚJO A, FACHINI A, et al. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment[J]. Journal of Hazardous Materials, 2010, 175: 45-95. doi: 10.1016/j.jhazmat.2009.10.100
[14] GODOY A A, DOMINGUES I, NOGUEIRA A J A, et al. Ecotoxicological effects, water quality standards and risk assessment for the anti-diabetic metformin[J]. Environmental Pollution, 2018, 243: 534-542. doi: 10.1016/j.envpol.2018.09.031
[15] LIU J C, DAN X X, LU G G, et al. Investigation of pharmaceutically active compounds in an urban receiving water: Occurrence, fate and environmental risk assessment[J]. Ecotoxicology and Environmental Safety, 2018, 154: 214-220. doi: 10.1016/j.ecoenv.2018.02.052
[16] DJEBBI E, YAHIA M N D, FARCY E, et al. Acute and chronic toxicity assessments of 17β-estradiol (E2) and 17α-ethinylestradiol (EE2) on the calanoid copepod Acartia clausi: Effects on survival, development, sex-ratio and reproduction[J]. Science of the Total Environment, 2022, 807: 150845. doi: 10.1016/j.scitotenv.2021.150845
[17] SANDERSON H, JOHNSON D J, WILSON C J, et al. Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening[J]. Toxicology Letters, 2003, 144: 383-395. doi: 10.1016/S0378-4274(03)00257-1
[18] HERNANDO M D, MEZCUA M, FERNÁNDEZ-ALBA A R, et al. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments[J]. Talanta, 2006, 69: 334-342. doi: 10.1016/j.talanta.2005.09.037
[19] 尹承南, 谢培, 焦萌, 等. 天津市地表水体54种PPCPs分布特征[J]. 环境化学, 2021, 40(9): 2820-2831. doi: 10.7524/j.issn.0254-6108.2020042901
[20] 任丙南, 耿静. 三亚市水体中PPCPs的污染水平、分布特征及生态风险评价[J]. 环境科学, 2021, 42(10): 4717-4726.
[21] 罗嘉豪, 王煜凯, 原珂, 等. 广东省药物活性化合物的污染特征及生态风险评价[J/OL]. 环境科学, 2023: 1-16.
[22] ZHANG Y Z, DUAN L, WANG B, et al. Efficient multiresidue determination method for 168 pharmaceuticals and metabolites: Optimization and application to raw wastewater, wastewater effluent, and surface water in Beijing, China[J]. Environmental Pollution, 2020, 261: 114113. doi: 10.1016/j.envpol.2020.114113
[23] 李建忠. 典型内分泌干扰物在土壤中迁移转化规律研究[D]. 北京: 清华大学, 2013.
[24] SCHEURER M, MICHEL A, BRAUCH H J, et al. Occurrence and fate of the antidiabetic drug metformin and its metabolite guanylurea in the environment and during drinking water treatment[J]. Water Research, 2012, 46: 4790-4802. doi: 10.1016/j.watres.2012.06.019
[25] CRAGO J, BUI C, GREWALS, et al. Age-dependent effects in fathead minnows from the anti-diabetic drug metformin[J]. General and Comparative Endocrinology, 2016, 232: 185-190. doi: 10.1016/j.ygcen.2015.12.030
[26] 张玲丽. UV/H2O2对水中诺氟沙星和硝苯地平的降解研究[D]. 济南: 山东师范大学, 2017.
[27] Wang L, Ying G G, Zhao J L, et al. Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China[J]. Science of the Total Environment, 2010, 408: 3139-3147. doi: 10.1016/j.scitotenv.2010.04.047
[28] 张盼伟, 周怀东, 赵高峰, 等. 北京城区水体中PPCPs的分布特征及潜在风险[J]. 环境科学, 2017, 38(5): 1852-1862.
[29] HAYASHI Y, HECKMANN L H, CALLAGHAN A, et al. Reproduction recovery of the crustacean Daphnia magna after chronic exposure to ibuprofen[J]. Ecotoxicology, 2008, 17: 246-251. doi: 10.1007/s10646-008-0191-3
[30] 刘慧娟, 张建明, 谢姣. 典型PPCPs类污染物的毒作用及污染物去除方法概述[J]. 山东化工, 2023, 52(16): 232-234. doi: 10.3969/j.issn.1008-021X.2023.16.066
[31] MAJUMDER A, GUPTA B, GUPTA A K. Pharmaceutically active compounds in aqueous environment: A status, toxicity and insights of remediation[J]. Environmental Research, 2019, 176: 108542. doi: 10.1016/j.envres.2019.108542
[32] LA FARRÉ M, PÉREZ S, KANTIANI L, et al. Fate and toxicity of emerging pollutants, their metabolites and transformation products in the aquatic environment[J]. Trends in Analytical Chemistry, 2008, 27(11): 991-1007. doi: 10.1016/j.trac.2008.09.010
[33] DELORENZO M E, FLEMING J. Individual and mixture effects of selected pharmaceuticals and personal care products on the marine phytoplankton species Dunaliella tertiolecta[J]. Archives of Environmental Contamination and Toxicology, 2008, 54: 203-210. doi: 10.1007/s00244-007-9032-2